A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia
Clinical trial NCT04091438 · COMPLETED
Trial details
- NCT number
- NCT04091438
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-26
- Primary completion
- 2020-11-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.